Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-002422-78Phase 4Completed
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide arm with Sitagliptin arm (2 arms). Primary endpoint: Change in left ventricular diastolic dysfunction. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-002422-78.